ArticleDer Urologe. Ausg. A2019

[Metronomic chemotherapy with oral cyclophosphamide : An individual option for the metastatic castration-resistant prostate cancer patient?]

S Knipper et al.PubMed ↗Publisher ↗

No numbers read from the abstract.